3659 results for «381»
3659 results
Valve and structural: challenges and innovations
11 Oct 2025 – From AICT-AsiaPCR 2025
This session explores innovative approaches and challenges in valve and structural interventions, including expanding transcatheter techniques for ruptured sinus of Valsalva closure and prophylactic chimney stenting in high-risk TAVI patients. It also presents long-term outcomes of left main PCI according to stenting methods, comparative strategies in...
Renal, inflammation and protection strategies in PCI
11 Oct 2025 – From AICT-AsiaPCR 2025
Delve into renal protection and inflammation management strategies in PCI, with a focus on renal blood flow indicators in chronic heart failure, the protective role of exosomes in myocardial ischemia, and efficacy of renal guard devices against contrast-induced nephropathy. The session also examines radial artery occlusion...
Drug-coated balloons: a PREVAIL-ing gamechanger in complex PCI
11 Oct 2025 – From AICT-AsiaPCR 2025
Focus on the evolving role of drug-coated balloons (DCB) in complex PCI, extending their use beyond traditional indications to challenging coronary lesions and high-risk patient populations. This session reviews clinical data from the SCAAR Prevail registry and discusses the evidence journey supporting broader advocacy for DCB...
CTO techniques and strategies
11 Oct 2025 – From AICT-AsiaPCR 2025
Explore advanced techniques and strategic approaches in chronic total occlusion (CTO) interventions, including novel methods for severely calcified lesions, bifurcation management, and complex anatomies such as right main CTOs. The session highlights epicardial collateral navigation, device synergy for calcified coronary disease, indigenous perforation techniques, and ultra-low...
AICT-AsiaPCR 2025 Awards ceremony
11 Oct 2025 – From AICT-AsiaPCR 2025
The AICT-AsiaPCR 2025 Awards ceremony celebrates outstanding achievements and innovations in the field of interventional cardiology. This event recognizes the contributions of clinicians and researchers who have advanced cardiovascular care and highlights excellence across various domains within the specialty.
AICT-AsiaPCR 2025 Closing ceremony
11 Oct 2025 – From AICT-AsiaPCR 2025
The AICT-AsiaPCR 2025 Closing ceremony marks the culmination of a comprehensive Course, reflecting on key scientific advancements, collaborative achievements, and the shared commitment to advancing cardiovascular medicine and patient care.
AICT-AsiaPCR 2025 Opening ceremony
10 Oct 2025 – From AICT-AsiaPCR 2025
The AICT-AsiaPCR 2025 Opening Ceremony marked the commencement of the conference's comprehensive program, setting the stage for cutting-edge discussions and advancements in interventional cardiology across the Asia-Pacific region.
TAVI and aortic valve procedures
11 Oct 2025 – From AICT-AsiaPCR 2025
Focusing on transcatheter aortic valve interventions, this session covers a broad spectrum of complex cases including emergent TAV-in-SAV procedures, management of severely calcified bicuspid valves, zero-contrast TAVI techniques, and strategies for hostile anatomies. It provides valuable insights into procedural planning and follow-up to optimize patient care...
We CARE in 2023: Measuring the pandemic’s impact and developing tools to build resilience for the future
18 May 2023
The COVID-19 pandemic caused huge disruption to healthcare services and dramatically reduced hospital admissions for MI.1 In response, the We CARE initiative was created from a collaboration between PCR and Stent – Save a Life! to rebuild patient confidence in pursuing timely medical treatment and to help...
We CARE about hearts - EuroPCR 2022
19 May 2022
The aims of We CARE are to rebuild patient confidence and help stakeholders provide effective and timely cardiac care through knowledge, education and training.
Author
We CARE: a joint initiative by PCR and Stent – Save a Life!
07 May 2021
Paris, France. Since the start of the COVID-19 pandemic, patients have been consistently deprived of timely cardiovascular treatment. This is due in part to measures taken in response to the sanitary crisis, but it is also due to patients' own unwillingness to seek medical help, even...
The GUIDE-DES Trial - QCA versus IVUS guidance for DES implantation
27 Aug 2023
Quantitative coronary angiography-guidance versus intravascular ultrasound-guidance for drug-eluting stent implantation (GUIDE-DES trial): A multicenter, non-inferiority, randomised-controlled trial
Nicola Ryan provides her take on the final results of GUIDE-DES which were presented by Taeoh Kim during the ESC 2023 congress in Amsterdam.
Note the assumptions in this article are based on the presentation...
Author
AIMI-HF trial - Ischemia and viability imaging in heart failure: The alternative imaging modalities in ischemic heart failure trial
05 Mar 2023
Nicola Ryan provides her take on this clinical trial presented by Lisa Mielniczuk at the American College of Cardiology Scientific Session (ACC.23/WCC) – note this analysis is based upon the presented slides alone.
Author
Fractional flow reserve-guided complete or culprit-only PCI in patients with ST-elevation myocardial Infarction - FULL REVASC
08 Apr 2024
Nicola Ryan provides her take on the FULL REVASC trial which was presented at ACC.24 in Atlanta and published Simultaneously in NEJM.
The FULL REVASC trial is a multicentre registry-based randomised control trial comparing FFR-guided complete revascularisation of non-culprit lesions versus culprit lesion PCI alone in patients presenting...
Author
The CLEAR SYNERGY (OASIS 9) Trial: A 2x2 factorial randomized controlled trial of colchicine versus placebo and spironolactone versus placebo in patients with myocardial infarction
18 Nov 2024
Mirvat Alasnag provides her take on the CLEAR SYNERGY trial presented by Sanjit S Jolly at AHA 2024 in Chicago.
Author
TAILORED-CHIP: Tailored antiplatelet therapy for complex high-risk PCI
29 Aug 2025
Nicola Ryan provides her take on the results of TAILORED-CHIP presented by Duk-Woo Park at the ESC Congress 2025 in Madrid.
Author
The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation
01 Sep 2025
Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.
Author
![The AQUATIC trial [Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation: Rationale for and design of the AQUATIC double-blind randomized trial]](https://www.pcronline.com/var/pcrov3/storage/images/pcronline/news/congress-coverages/esc/2025/aquatic-trial-quitting-versus-using-aspirin-therapy-patients-stabilized-cad-stenting-long-term-oral-anticoagulation/27448089-9-eng-GB/The-AQUATIC-trial-Assessment-of-quitting-versus-using-aspirin-therapy-in-patients-with-stabilized-coronary-artery-disease-after-stenting-who-requi_image_responsive_6.jpg)
OPTION-STEMI: Immediate versus staged complete revascularisation during index admission in patients with STEMI and multivessel disease
02 Sep 2025
Mirvat Alasnag provides her take on OPTION-STEMI, presented by Youngkeun Ahn at ESC Congress 2025 in Madrid.
Author
Evidence base: A description of the key, so far published, studies in the space of drug coated balloons
23 Jan 2025
Authored by Hector Garcia-Garcia and Jorge Sanz-Sanchez, this article examines pivotal randomized clinical trials on drug-coated balloons in coronary artery disease. It highlights their role in managing in-stent restenosis, de novo small vessel lesions, and large vessel lesions while exploring future directions through ongoing trials.
Author
Author
